Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. | Signal Transduct Target Ther | 2023 | 36646695 | PubTator, text mining | PubMed |
| Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform. | iScience | 2023 | 36644320 | PubTator, text mining | PubMed |
| Genetic Encoding of a Photocaged Histidine for Light-Control of Protein Activity. | Chembiochem | 2023 | 36642698 | PubTator, text mining | PubMed |
| Proximity-enhanced protein crosslinking through an alkene-tetrazine reaction. | Bioorg Chem | 2023 | 36642019 | PubTator, text mining | PubMed |
| High expression of KIF20A in bladder cancer as a potential prognostic target for poor survival of renal cell carcinoma. | Medicine (Baltimore) | 2023 | 36637953 | PubTator, text mining | PubMed |
| An atlas of substrate specificities for the human serine/threonine kinome. | Nature | 2023 | 36631611 | PubTator, text mining | PubMed |
| MycoNews 2022: editorial, news, reports, awards, personalia, and book news. | IMA Fungus | 2023 | 36624519 | PubTator, text mining | PubMed |
| High throughput sequencing revealed enhanced cell cycle signaling in SLE patients. | Sci Rep | 2023 | 36599883 | PubTator, text mining | PubMed |
| Pharmacological Activities and Pharmacokinetics of Glycycoumarin. | Rev Bras Farmacogn | 2023 | 36567915 | PubTator, text mining | PubMed |
| Native Size-Exclusion Chromatography-Based Mass Spectrometry Reveals New Components of the Early Heat Shock Protein 90 Inhibition Response Among Limited Global Changes. | Mol Cell Proteomics | 2023 | 36549590 | PubTator, text mining | PubMed |
| Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma. | Thorac Cancer | 2023 | 36507553 | PubTator, text mining | PubMed |
| A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study. | Cancer Immunol Immunother | 2023 | 36445410 | PubTator, text mining | PubMed |
| Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer. | Apoptosis | 2023 | 36436119 | PubTator, text mining | PubMed |
| A comprehensive atlas of epigenetic regulators reveals tissue-specific epigenetic regulation patterns. | Epigenetics | 2023 | 36305095 | PubTator, text mining | PubMed |
| The peritumoral brain zone in glioblastoma: where we are and where we are going. | J Neurosci Res | 2023 | 36300592 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| A new discriminant strategy combined with four TIRADS screening procedures increases ultrasound diagnostic accuracy-focusing on "wrong diagnostic" thyroid nodules. | Eur Radiol | 2023 | 36169690 | PubTator, text mining | PubMed |
| Adrenal insufficiency is common amongst kidney transplant recipients receiving maintenance prednisolone and can be predicted using morning cortisol. | Nephrol Dial Transplant | 2023 | 35561734 | PubTator, text mining | PubMed |
| Specific Regulation of m6A by SRSF7 Promotes the Progression of Glioblastoma. | Genomics Proteomics Bioinformatics | 2023 | 34954129 | PubTator, text mining | PubMed |
| Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients. | Cancer Res Commun | 2022 | 36970725 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=17